Clinical Trial Update: A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health and Disease

View source ↗

Summary

The pilot feasibility trial on fibroblast calcium and glucoregulation for Type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Kentucky | Conditions: Type 2 Diabetes | Status: WITHDRAWN